A large study adds to evidence that the main ingredient in Novo Nordisk's injectable GLP-1 drug for type 2 diabetes may ...

GLP-1 drugs mimic the GLP-1 hormone, which helps control insulin and blood sugar levels, decreases appetite and slows digestion of food. Initially approved to control diabetes, the drugs’ ...

WE’VE heard celebrities talk about the positives of Ozempic and other fat loss jabs – but there’s also a host of nasty side ...

The prevalence of U.S. adults without diabetes who filled a GLP-1 receptor agonist prescription rose from 0.1% in 2018 to 0.4 ...

Ask a Doctor is new series of physician-authored columns offering insights and advice on common health topics. It is not a ...

Novo Nordisk's Ozempic has been shown to improve waking distance and quality of life in people with type 2 diabetes (T2D) and ...

SaveHealth explores what the research says about Ozempic's effects on insulin resistance and related conditions.

MIT scientists have created a method to "paint" GLP-1 drugs onto antibodies inside the body, achieving longer-lasting effects ...

Novo Nordisk already has broad FDA approvals in hand for its injected semaglutide products Ozempic and Wegovy to reduce the ...

While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...

Equinox's GLP-1 protocol is considered a framework for people taking the drugs, one that addresses workout intensity, ...

Ozempic (semaglutide) is a brand-name injection pen used to treat type 2 diabetes. Meanwhile, Mounjaro (tirzepatide) is a ...